Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry
- PMID: 1836019
- PMCID: PMC6575286
- DOI: 10.1523/JNEUROSCI.11-12-03877.1991
Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry
Abstract
Dysmorphic alterations of dendritic arbors and spines in spiny striatal neurons were identified in section-Golgi impregnations of moderate and severe grades of Huntington's disease (HD). These alterations could be characterized as either proliferative or degenerative changes. Proliferative changes included prominent recurving of distal dendritic segments, short-segment branching along dendrites, and increased numbers and size of dendritic spines. Degenerative alterations consisted of truncated dendritic arborizations, occasional focal dendritic swellings, and marked spine loss. Proliferative changes were found primarily in moderate grades of HD, while degenerative changes were predominantly found in severe grades. Cytopathologic changes increased with neuropathologic severity. Similar morphologic alterations were observed in calbindin D28k (Calb) stained neurons in HD striatum. The immunoreactive intensity of Calb staining was increased in the distal dendrites of positive neurons in HD striatum. The present findings provide morphologic and quantitative evidence that confirms an early and marked involvement of spiny striatal neurons in HD and suggest that neuronal growth, rather than degeneration, may be the harbinger of cell death in this disorder.
Similar articles
-
Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease.Neuroscience. 1995 Mar;65(2):397-407. doi: 10.1016/0306-4522(94)00494-p. Neuroscience. 1995. PMID: 7777157
-
Increased calbindin-D28k immunoreactivity in striatal projection neurons of R6/2 Huntington's disease transgenic mice.Neurobiol Dis. 2005 Dec;20(3):907-17. doi: 10.1016/j.nbd.2005.05.023. Epub 2005 Jun 28. Neurobiol Dis. 2005. PMID: 15990326
-
Calbindin D28K as a marker for the degeneration of the striatonigral pathway in Huntington's disease.Brain Res. 1990 Aug 20;525(2):209-14. doi: 10.1016/0006-8993(90)90866-a. Brain Res. 1990. PMID: 2147568
-
Substance P and substance P receptor histochemistry in human neurodegenerative diseases.Regul Pept. 1993 Jul 2;46(1-2):174-85. doi: 10.1016/0167-0115(93)90028-7. Regul Pept. 1993. PMID: 7692486 Review.
-
Mitochondrial fragmentation in neuronal degeneration: Toward an understanding of HD striatal susceptibility.Biochem Biophys Res Commun. 2017 Feb 19;483(4):1063-1068. doi: 10.1016/j.bbrc.2016.08.042. Epub 2016 Aug 8. Biochem Biophys Res Commun. 2017. PMID: 27514446 Review.
Cited by
-
6-shogaol against 3-Nitropropionic acid-induced Huntington's disease in rodents: Based on molecular docking/targeting pro-inflammatory cytokines/NF-κB-BDNF-Nrf2 pathway.PLoS One. 2024 Jul 15;19(7):e0305358. doi: 10.1371/journal.pone.0305358. eCollection 2024. PLoS One. 2024. PMID: 39008492 Free PMC article.
-
The epigenetics of aging and neurodegeneration.Prog Neurobiol. 2015 Aug;131:21-64. doi: 10.1016/j.pneurobio.2015.05.002. Epub 2015 Jun 11. Prog Neurobiol. 2015. PMID: 26072273 Free PMC article. Review.
-
Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington's disease.Nat Med. 2023 Nov;29(11):2866-2884. doi: 10.1038/s41591-023-02566-3. Epub 2023 Oct 9. Nat Med. 2023. PMID: 37814059 Free PMC article.
-
Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease.Eur Arch Psychiatry Clin Neurosci. 1994;243(5):249-55. doi: 10.1007/BF02191583. Eur Arch Psychiatry Clin Neurosci. 1994. PMID: 8172940
-
A Progressive Loss of phosphoSer138-Profilin Aligns with Symptomatic Course in the R6/2 Mouse Model of Huntington's Disease: Possible Sex-Dependent Signaling.Cell Mol Neurobiol. 2022 Apr;42(3):871-888. doi: 10.1007/s10571-020-00984-2. Epub 2020 Oct 27. Cell Mol Neurobiol. 2022. PMID: 33108594 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical